Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3
- PMID: 23407876
- PMCID: PMC3570257
- DOI: 10.3892/etm.2013.892
Expression of a tumor-associated gene, LASS2, in the human bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3
Abstract
Homo sapiens longevity assurance homolog 2 of yeast LAG1 (LASS2), a metastasis suppressor gene of human cancer, is the most abundantly expressed member of the ceramide synthase gene family. Expression of LASS2 has been reported in carcinomas of the prostate, liver and breast. However, there has been no report on the expression of LASS2 in human bladder cancer cell lines. In order to investigate the expression and potential role of this new tumor metastasis supressor gene in human bladder cancer, we compared the proliferation, metastasis and invasion among the BIU-87, T24, EJ and EJ-M3 human bladder cancer cell lines. The mRNA expression levels of the LASS2 gene were examined using real-time quantitative PCR (qPCR). The expression levels of LASS1 and LASS3 mRNA were used as references. The protein expression level of the LASS2 gene was detected using western blotting. The most aggressive of these four human cancer cell lines was observed to be EJ-M3. The expression of LASS2 mRNA was significantly correlated with diverse proliferation, metastasis and invasion. The expression levels of LASS1 and LASS3 mRNA were not correlated with these parameters. At the protein level, we observed that the more aggressive the cancer cell line, the lower the LASS2 protein expression level. Therefore, LASS2 expression may be correlated with the development and progression of human bladder cancer and may be a prognostic indicator for this cancer.
Keywords: Homo sapiens longevity assurance homolog 2 of yeast LAG1; biological characteristics; bladder cancer; expression.
Figures






Similar articles
-
The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer.Int J Mol Sci. 2023 Oct 27;24(21):15668. doi: 10.3390/ijms242115668. Int J Mol Sci. 2023. PMID: 37958652 Free PMC article. Review.
-
The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model.Oncol Lett. 2017 Nov;14(5):5149-5156. doi: 10.3892/ol.2017.6880. Epub 2017 Sep 4. Oncol Lett. 2017. PMID: 29113153 Free PMC article.
-
LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.Oncol Lett. 2017 Feb;13(2):661-668. doi: 10.3892/ol.2016.5514. Epub 2016 Dec 20. Oncol Lett. 2017. PMID: 28356943 Free PMC article.
-
Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma.Med Oncol. 2012 Sep;29(3):1921-7. doi: 10.1007/s12032-011-0026-6. Epub 2011 Jul 14. Med Oncol. 2012. PMID: 21755371
-
Silencing of a novel tumor metastasis suppressor gene LASS2/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity.J Cell Biochem. 2012 Jul;113(7):2356-63. doi: 10.1002/jcb.24106. J Cell Biochem. 2012. PMID: 22573553
Cited by
-
Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer.Dis Markers. 2019 Sep 15;2019:3875147. doi: 10.1155/2019/3875147. eCollection 2019. Dis Markers. 2019. PMID: 31636736 Free PMC article.
-
Electric pulse current stimulation increases electrophysiological properties of If current reconstructed in mHCN4-transfected canine mesenchymal stem cells.Exp Ther Med. 2016 Apr;11(4):1323-1329. doi: 10.3892/etm.2016.3072. Epub 2016 Feb 11. Exp Ther Med. 2016. PMID: 27073443 Free PMC article.
-
Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.Integr Cancer Ther. 2016 Mar;15(1):80-6. doi: 10.1177/1534735415596569. Epub 2015 Aug 27. Integr Cancer Ther. 2016. PMID: 26315609 Free PMC article.
-
The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer.Int J Mol Sci. 2023 Oct 27;24(21):15668. doi: 10.3390/ijms242115668. Int J Mol Sci. 2023. PMID: 37958652 Free PMC article. Review.
-
Updates on the Pivotal Roles of Mitochondria in Urothelial Carcinoma.Biomedicines. 2022 Oct 1;10(10):2453. doi: 10.3390/biomedicines10102453. Biomedicines. 2022. PMID: 36289714 Free PMC article. Review.
References
-
- Morgan TM, Keegan KA, Clark PE. Bladder cancer. Curr Opin Oncol. 2011;23:275–282. - PubMed
-
- Saffar H, Sanii S, Heshmat R, et al. Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma. Am J Clin Pathol. 2011;135:454–460. - PubMed
-
- Kim SH, Lee SY, Park HR, et al. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer. 2011;117:1864–1873. - PubMed
-
- Polanski R, Maguire M, Nield PC, et al. MDM2 interacts with NME2 (non-metastatic cells 2, protein), and suppresses the ability of NME2 to negatively regulate cell motility. Carcinogenesis. 2011;32:1133–1142. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases